書誌事項
- タイトル別名
-
- A New Marker Substance for Neuroblastoma : Nervous System Specific Enolase (NSE) in Sera Determined with a Sensitive Enzyme Immunoassay
- シンケイ ガサイボウシュ ノ アタラシイ ケッチュウ マーカー ブッシツ Ne
この論文をさがす
説明
Serum levels of nervous system-specific enolase (NSE) in patients with neuroblastoma and in control subjects were determined with a sensitive solid-phase sandwich enzyme immunoassay system, using a mono-specific antibody to the γ subnit of rat NSE for solid-phase preparation and for enzyme-labeled antibody. Using this assay system, the NSE in human sera can be estimated with a minimum measurable consentration of 0.6ng γγ equivalent/ml, with less than 10% of coefficients of variation for within-run (n=20) and between-run (n=15) assays. Serum levels of NSE in healthy adults ranged from 1.4-5.7ng/ml (2.87±1.18ng/ml, n=20), and those in control children (1-7 years old) were from 2.6 to 10.8ng/ml (5.76±2.42ng/ml, n=20). Serum samples (n=11) from patients with neuroblastoma contained high levels of NSE, distributing 13.6 to 330ng/ml (mean, 107ng/ml), however those from ganglioneuroblastoma patients were within a normal range (3.0-25.0ng/ml, mean, 8.3ng/ml). These results suggest that the NSE in serum might be a valuable marker substance for the screening and therapeutic monitoring of neuroblastoma.
収録刊行物
-
- Journal of the Japanese Society of Pediatric Surgeons
-
Journal of the Japanese Society of Pediatric Surgeons 18 (7), 1303-1309, 1982
特定非営利活動法人 日本小児外科学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390001204805346816
-
- NII論文ID
- 110002095962
-
- NII書誌ID
- AN00192281
-
- ISSN
- 21874247
- 0288609X
-
- NDL書誌ID
- 2619890
-
- 本文言語コード
- ja
-
- データソース種別
-
- JaLC
- NDL
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可